Filing metadata

Accession number
0001140361-24-000469
Form type
Form 4
Filer
Ernexa Therapeutics Inc.
CIK
CIK 748592
Filed
Jan 03, 2024
Reporting period
Jan 01, 2024
Description
Insider transaction

Explore SEC Filings Hub